Alnylam Pharmaceuticals
ALNY
#770
Rank
HK$260.95 B
Marketcap
HK$1,950
Share price
0.47%
Change (1 day)
-46.50%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company